Infectious Disease Frontier Archives - Page 29 of 37

IDWeek Highlights | Dr. Hong-mei Xu: Consistency Evaluation of Congenital CMV Infection in Dried Blood Spots and Plasma PCR Testing

By Peter W. PENG 2023.11.28

Editor's Note: Newborns can be infected with congenital cytomegalovirus (CMV) through vertical mother-to-child transmission, and CMV infection screening is required for some newborns with specific indications. Polymerase chain reaction (PCR)…

Dr. Chun-rong Ju: Lung Transplant Recipients Receive Prolonged Contezolid Treatment for Nocardia Infection

By Peter W. PENG 2023.11.28

Editor's note: Nocardia is a conditional pathogen, and infections are common in immunocompromised populations such as organ transplant recipients. Professor Chunrong Ju and her team at the First Affiliated Hospital…

IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?

By Peter W. PENG 2023.11.28

Editor's Note: "Experiencing weight gain due to medication" is a common concern for many people living with HIV (PLWH). Some antiretroviral therapy (ART) regimens are associated with weight gain and…

IDWeek Interview | Dr. Shields: Real-World Study on the Efficacy of Two Generation BL-BLI Combination Therapy for MDR-PA

By Peter W. PENG 2023.11.28

Editor's Note: Ceftolozane-tazobactam is a new BL-BLI combination drug, and ceftolozane is a third-generation cephalosporin antibiotic, and tazobactam is a beta-lactamase inhibitor. At the recent 2023 IDWeek in the United…

Can MRSA Surveillance Results Be Used to Discontinue Vancomycin for Infections Other Than Pneumonia?

By Peter W. PENG 2023.11.28

Editor's Note: At the IDWeek 2023, Dr. Rebekah W. Moehring from the Duke Center for Antimicrobial Stewardship and Infection Control at Duke University presented a fascinating report on the use…

IDWEEK Live Interview | Dr. Thomas L. Holland：Careful consideration when selecting clinical outcomes brings more possibilities to clinical trials of bacterial diseases

By Peter W. PENG 2023.11.28

Editor's Note: Staphylococcus aureus bacteremia is a major cause of bloodstream infections, and hospital-acquired bacterial pneumonia is often caused by multidrug-resistant bacteria. And developing new antibiotics requires patient-centered clinical outcomes.…

IDWeek Commentary | Dr. Yonghong Xiao: Intestinal colonization with MDRO, horizontal transmission and risk for bloodstream infection

By Peter W. PENG 2023.11.27

Editor's Note: Bacterial drug resistance is a significant challenge in the global public health field. Multidrug-resistant organisms (MDROs), represented by carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa…

Infectious Disease Frontier

IDWeek Highlights | Dr. Hong-mei Xu: Consistency Evaluation of Congenital CMV Infection in Dried Blood Spots and Plasma PCR Testing

Dr. Chun-rong Ju: Lung Transplant Recipients Receive Prolonged Contezolid Treatment for Nocardia Infection

IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?

IDWeek Interview | Dr. Shields: Real-World Study on the Efficacy of Two Generation BL-BLI Combination Therapy for MDR-PA

Can MRSA Surveillance Results Be Used to Discontinue Vancomycin for Infections Other Than Pneumonia?

IDWEEK Live Interview | Dr. Thomas L. Holland：Careful consideration when selecting clinical outcomes brings more possibilities to clinical trials of bacterial diseases

IDWeek Commentary | Dr. Yonghong Xiao: Intestinal colonization with MDRO, horizontal transmission and risk for bloodstream infection

IDWeek Live interview: Clinical Trials in Fungal Diseases That May Change Your Practice

IDWeek Live Interview | Dr. Murat Akova: When to Discontinue Antibiotics in Febrile Neutropenia?

IDWeek Live Interview | Dr. Patty Wright Summarizes Hot Topics in the Field of Infectious Diseases